| 1 |
How does the concept of “model as a dataset” reshape traditional data-sharing practices in medical imaging?
|
1. It removes the need for regulatory approval of medical data. |
|
Generative AI models can act as surrogates for real datasets, allowing researchers to share synthetic medical images instead of patient data.
This reduces privacy concerns and facilitates collaborative research without transferring sensitive patient information. |
Section discussing privacy-preserving image synthesis and the use of “models as datasets” to share clinical data safely. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which analytical conclusion can be drawn about the trade-offs between physics-informed and statistical models?
|
|
|
Physics-informed models ensure consistency with imaging principles and interpretability, while statistical models (e.g., GANs, VAEs) produce more diverse and realistic images but may lack physical plausibility.
There is a trade-off between interpretability and flexibility; statistical models risk artifacts, while physics-informed models may be too constrained. |
Discussion on physics-informed vs. statistical models and the image generation trilemma (quality vs. diversity vs. speed). |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
Why is “mode collapse” considered a critical problem in GAN-based medical image synthesis?
|
|
|
Mode collapse causes GANs to generate a limited range of outputs, failing to capture the full diversity of medical conditions.
Rare but clinically important pathologies may be missed, reducing the utility of synthetic datasets for training diagnostic AI. |
Section describing GAN limitations and the risk of reduced diversity in medical image synthesis. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Why are healthcare-specific metrics preferred over general-purpose metrics such as FID or SSIM?
|
4. They eliminate human evaluation entirely. |
|
Healthcare-specific metrics evaluate the clinical relevance of images, such as lesion visibility and tissue contrast, rather than just visual similarity. For synthetic medical images to be useful in practice, they must preserve diagnostically important features that general metrics cannot capture. |
Discussion emphasizing the need for domain-specific evaluation metrics in medical imaging AI. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What does the article identify as the key tension between privacy preservation and image fidelity?
|
2. Privacy protection always lowers model accuracy. |
|
Increasing privacy (e.g., via obfuscation) can reduce image fidelity, while prioritizing fidelity may risk revealing patient-identifiable patterns.
There is an inherent trade-off between protecting patient privacy and maintaining clinically useful detail in synthetic images. |
Section on privacy-fidelity trade-offs in generative medical imaging. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
Why is the FDA’s approval of synthetic MRI technology significant for future AI-generated data?
|
|
|
FDA approval validates that AI-generated medical images can meet safety, reliability, and clinical utility standards.
Regulatory endorsement allows broader adoption of synthetic data for research and potentially clinical use. |
Discussion on regulatory milestones and implications of FDA clearance for AI-generated medical images. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
Which strategy would best mitigate demographic bias in generative models according to the article?
|
|
|
ncorporating diverse, representative datasets and disaggregating subgroups during model training.
Ensures that rare or minority populations are adequately represented, reducing biased outputs. |
Discussion on mode collapse, dataset representation, and demographic biases in GANs and VAEs. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
How do DDPMs exemplify versatility in healthcare image synthesis?
|
5. They require constant human supervision. |
|
DDPMs can generate high-quality, diverse images while allowing controllable denoising steps to tailor outputs.
Their stepwise diffusion process provides flexibility for creating realistic images across various modalities. |
Section comparing VAEs, GANs, and DDPMs in medical imaging synthesis. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
What analytical insight does the article provide about integrating AI-generated medical images into education and research?
|
3. It is limited to postgraduate training only. |
|
AI-generated images can safely expand datasets for training, simulation, and research without patient privacy concerns.
Synthetic data increases exposure to rare pathologies and reduces dependency on limited real-world datasets. |
Sections on “model as a dataset” and applications in research/education |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
Why is regional calibration essential when applying risk prediction models across countries?
|
|
|
Because baseline ASCVD incidence, stroke-to-CHD ratios, and risk factor prevalence differ across regions.
Without recalibration, Western-derived models overestimate risk in East Asian populations, misguiding treatment. |
Discussion of overestimation by FRS and PCE in Japan, Korea, and China. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What analytical conclusion can be drawn when comparing the China-PAR and Framingham models?
|
|
|
China-PAR provides more accurate, region-specific risk estimates by using local cohort data.
Framingham overestimates CHD risk in East Asians due to different baseline risk and population characteristics. |
Sections describing the development of national risk scores using native cohorts. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Based on CVD mortality data, what analytical inference can be made about Japan’s position compared to neighboring countries?
|
|
|
Japan has relatively lower CHD mortality but higher stroke rates compared with Korea and China.
Indicates regional heterogeneity in disease burden, emphasizing the need for country-specific risk models. |
Epidemiology section comparing ASCVD prevalence and mortality in East Asian countries. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What analytical limitation arises when using Western-derived coefficients in East Asian models?
|
|
|
Risk is overestimated, and predictions may not accurately reflect population-specific disease patterns.
Western cohorts have higher CHD incidence and different lifestyle factors; applying them directly leads to misclassification. |
Discussion of PCE/FRS overestimating ASCVD risk in East Asian populations. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What policy implication can be derived from country-specific risk models?
|
|
|
Health authorities should implement locally validated risk scores to guide prevention strategies and resource allocation.
Policies based on inaccurate Western models may result in overtreatment or misallocation of resources. |
Future directions emphasizing need for standardized regional ASCVD risk calculators and guideline adoption. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
If a model excludes socioeconomic variables, what analytical consequence might occur?
|
|
|
The model may underestimate risk in disadvantaged populations and fail to capture social determinants of health.
Socioeconomic factors influence lifestyle, access to care, and overall ASCVD risk; omitting them reduces model accuracy. |
Sections discussing gaps in understanding ASCVD risk factors in East Asian immigrants. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
How might AI improve next-generation ASCVD risk prediction in East Asia?
|
|
|
AI could integrate large multi-country datasets, novel biomarkers, imaging data, and lifestyle factors to refine personalized risk.
Machine learning models can handle complex interactions and heterogeneity, improving accuracy beyond traditional calculators. |
Future directions highlighting potential of AI, risk-enhancing factors, and multinational registries. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What conclusion can be drawn from comparing Mongolia’s and South Korea’s CVD mortality rates?
|
|
|
Mongolia has higher age-standardized and crude CVD mortality rates compared with South Korea, indicating a greater overall cardiovascular burden.
This suggests differences in healthcare infrastructure, prevalence of risk factors such as hypertension and smoking, and possibly disparities in early detection or preventive care. While South Korea shows lower mortality, reflecting successful public health interventions and widespread screening programs, Mongolia’s higher rates highlight the need for targeted national policies and risk prediction models adapted to local population characteristics. |
Epidemiology section and discussion of country-specific ASCVD mortality, emphasizing heterogeneity of CVD outcomes among East Asian countries. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What is the most logical future direction for improving ASCVD models across East Asia?
|
|
|
Current national models are limited by lack of external validation, heterogeneity, and incomplete representation of East Asian populations. A collaborative multinational approach can create more generalizable models, facilitate cross-validation, and account for differences in stroke-to-CHD ratios, lifestyle factors, and environmental exposures across countries. AI and machine learning could enhance model sophistication by handling complex interactions and identifying population-specific risk enhancers. |
Future directions and conclusions section emphasizing multinational registries, standardized ASCVD definitions, and the potential of AI to improve risk prediction. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
According to the “image generation trilemma” shown in the figure, what analytical conclusion can be drawn about the relative strengths of VAEs, GANs, and DDPMs in medical image synthesis?
|
|
|
The trilemma illustrates a trade-off between fidelity, diversity, and training stability. VAEs are stable and explainable but compromise image fidelity; GANs excel in visual realism but require careful tuning to avoid collapse; DDPMs combine strengths of both, allowing high-fidelity, diverse outputs while mitigating extreme instabilities. This makes DDPMs particularly suitable for synthesizing complex medical images while maintaining clinical relevance. |
Section comparing VAEs, GANs, and DDPMs, and the “image generation trilemma” figure. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
Based on Figure, what analytical conclusion can be drawn regarding the distribution of cardiovascular disease (CVD) subtypes across East Asian countries?
|
|
|
troke is relatively more prevalent than coronary heart disease (CHD) in East Asian countries like Japan, Korea, and China, whereas CHD rates are comparatively lower. This pattern contrasts with Western populations, where CHD predominates. Differences in lifestyle, diet, genetic factors, and hypertension prevalence contribute to a higher stroke burden. Such disparities indicate that applying Western risk prediction models directly can misestimate absolute ASCVD risk, especially CHD risk, emphasizing the need for regional calibration and inclusion of stroke as a primary endpoint in risk models. |
Sections discussing epidemiology of ASCVD, country-specific differences in CHD versus stroke incidence, and overestimation of CHD risk by Western models. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|